Why Pregnancy Changes the Vitamin D Equation

Roughly 40–80% of pregnant women worldwide have 25-hydroxyvitamin D (25(OH)D) levels below 30 ng/mL, the threshold most clinical guidelines use to define sufficiency. That range varies by latitude, skin tone, and season — but the pattern is consistent enough that researchers treat gestational vitamin D deficiency as a global public health problem. Demand rises from the first trimester onward: the fetus relies entirely on maternal circulation for vitamin D, and the placenta actively converts 25(OH)D into its active hormone form, 1,25-dihydroxyvitamin D, at rates that increase as pregnancy progresses.

The stakes are specific. Maternal deficiency during pregnancy has been linked to preeclampsia, gestational diabetes, preterm birth, low birth weight, and — for the newborn — skeletal underdevelopment and neonatal hypocalcemia. A 2019 meta-analysis in Nutrients reviewed 31 studies and found that women with 25(OH)D below 20 ng/mL had significantly higher odds of preeclampsia and gestational diabetes compared with those in the sufficient range. These are not subtle associations.

What 'Sufficient' Means During Pregnancy — and Why It's Contested

The Institute of Medicine's 2010 recommendation of 600 IU/day for pregnant women targets a 25(OH)D level of at least 20 ng/mL (50 nmol/L). Most obstetric and nutrition researchers now consider that floor too low for pregnancy specifically. The Endocrine Society recommends 1,500–2,000 IU/day for pregnant and lactating women to consistently maintain levels above 30 ng/mL. Some researchers argue the optimal range in pregnancy sits closer to 40–60 ng/mL (100–150 nmol/L), particularly for immune function and fetal bone programming.

A frequently cited trial, the VDAART study, published in JAMA, supplemented women with 4,400 IU/day during pregnancy and found significantly higher 25(OH)D levels at birth — without adverse events — compared with the standard 400 IU/day group. That trial helped shift clinical thinking toward higher supplementation targets than prenatal vitamins typically contain.

Trimester-Level Changes in Vitamin D Status

Vitamin D status doesn't stay flat across pregnancy. Several cohort studies show 25(OH)D declining from the first to the third trimester even in women who supplement, likely because fetal demand accelerates in the second half of pregnancy while the mother's renal handling of calcium and vitamin D metabolites shifts substantially.

First Trimester

Placental 1-alpha-hydroxylase activity begins early, converting maternal 25(OH)D to active 1,25-dihydroxyvitamin D at elevated rates. This is why baseline 25(OH)D matters so much at conception: women who enter pregnancy deficient have no buffer. A cohort analysis published in The Journal of Clinical Endocrinology & Metabolism found that first-trimester 25(OH)D below 20 ng/mL was independently associated with a more than doubled risk of preeclampsia later in pregnancy.

Second Trimester

Skeletal mineralization of the fetus accelerates in the second trimester. Calcium absorption from the maternal gut — a process that depends on active vitamin D — roughly doubles compared to the non-pregnant state. Women with insufficient 25(OH)D during this window face greater demands on their own bone density to meet fetal calcium needs, a mechanism that contributes to postpartum bone loss.

Third Trimester

Fetal bone growth peaks in the third trimester, and cord blood 25(OH)D at delivery correlates strongly with maternal levels in the weeks before birth. A 2016 systematic review in BMC Pregnancy and Childbirth confirmed that cord blood 25(OH)D is roughly 60–80% of maternal levels — meaning a mother at 25 ng/mL delivers a newborn with levels in the deficient range. Neonates have no significant dietary intake until breast milk or formula is established, so what they are born with largely determines their early-infancy status.

How Much Sun Can Pregnant Women Realistically Rely On?

Sun exposure during pregnancy is not contraindicated — UVB-driven vitamin D synthesis works the same way physiologically for a pregnant woman as for anyone else. UVB from sunlight (wavelengths 280–315 nm) converts 7-dehydrocholesterol in skin to pre-vitamin D3, which then isomerizes to vitamin D3. A brief outdoor session at midday in summer at mid-latitude, with skin exposed, can generate 10,000–20,000 IU of vitamin D3 in lighter-skinned individuals.

The practical limits are real, though. As pregnancy progresses, heat sensitivity often makes midday outdoor time uncomfortable. Nausea in early pregnancy, mobility in late pregnancy, and simple schedule constraints all reduce the hours a pregnant woman realistically spends with substantial skin exposed. Many women also use high-SPF sunscreen consistently, which — as covered in detail in the Rays post on sunscreen and vitamin D synthesis — significantly reduces UVB penetration, though imperfect real-world application means it rarely eliminates synthesis entirely.

Geography matters critically. At latitudes above 35°N (roughly above Atlanta, Los Angeles, or Madrid), UVB is effectively zero for vitamin D synthesis during November through February regardless of time spent outdoors — the solar angle is too low. This is explained more fully in the guide to vitamin D at different latitudes. A pregnant woman in Edinburgh or Montreal in January cannot produce meaningful vitamin D from sun exposure regardless of how long she sits by a window or steps outside.

The conclusion for most pregnant women at higher latitudes, or during autumn and winter, is that sun cannot be the primary strategy. Testing 25(OH)D and adjusting supplements to close the gap is the more reliable approach.

Supplement Evidence: What Doses the Trials Support

The typical prenatal vitamin contains 400–600 IU of vitamin D — well below what research indicates most women need to maintain 25(OH)D above 30 ng/mL throughout pregnancy. A pivotal randomized trial by Hollis et al., published in the American Journal of Obstetrics and Gynecology, found that 4,000 IU/day from 12–16 weeks gestation to delivery was safe, significantly raised both maternal and cord blood 25(OH)D, and was not associated with any adverse outcomes. Importantly, women receiving 4,000 IU/day were significantly more likely to reach 40 ng/mL than those on 400 or 2,000 IU/day.

A 2019 Cochrane review of vitamin D supplementation in pregnancy, which covered 30 randomized trials, concluded that supplementation compared to no supplementation or placebo likely reduces the risk of preterm birth, low birth weight, and postpartum hemorrhage, and probably results in higher 25(OH)D levels at term — though the optimal dose remained uncertain due to trial heterogeneity. The full review is available through Cochrane Library.

For supplement form, D3 (cholecalciferol) raises 25(OH)D more effectively than D2 (ergocalciferol) and is the preferred form in pregnancy contexts, consistent with evidence reviewed in a 2012 analysis in the American Journal of Clinical Nutrition. D3 supplements are fat-soluble and should be taken with the largest meal of the day to maximize absorption.

What About Vitamin K2?

When supplementing vitamin D3 at higher doses during pregnancy, the case for pairing it with K2 (MK-7) is the same as outside pregnancy: K2 helps direct calcium toward bone rather than soft tissue. Pregnancy already increases calcium demands substantially, and there is preliminary evidence that combined D3 and K2 supplementation supports fetal bone mineralization more effectively than D3 alone, though large RCT data specific to pregnancy are still limited. Pregnant women should discuss K2 inclusion with a healthcare provider, particularly if they're on anticoagulants.

Testing During Pregnancy: When and How Often

The standard test is serum 25(OH)D — not 1,25-dihydroxyvitamin D, which is actively elevated during pregnancy and does not reflect stores. Testing at the first prenatal appointment establishes a baseline. A follow-up in the third trimester (around 28–32 weeks) is practical because it captures the period of highest fetal demand and allows dose adjustment before delivery.

Target 25(OH)D levels during pregnancy are generally cited at 30 ng/mL minimum, with many researchers and clinicians targeting 40–60 ng/mL based on observational data linking higher levels with better birth outcomes. Levels above 100 ng/mL carry toxicity risk, but this is essentially only achievable through sustained high-dose supplementation — sun exposure does not cause vitamin D toxicity.

Breastfeeding and the Postpartum Gap

Breast milk is a poor source of vitamin D. Even when a nursing mother has adequate 25(OH)D, breast milk typically contains only 25–80 IU per liter — far below the 400 IU/day recommended for infants. This means exclusively breastfed infants are at high risk of vitamin D deficiency unless supplemented directly.

One alternative approach with trial evidence is high-dose maternal supplementation. A randomized study in Pediatrics found that mothers taking 6,400 IU/day produced breast milk with enough vitamin D to adequately supply their infants without direct infant drops, compared with the standard 400 IU/day maternal dose. This remains an emerging option rather than standard practice, but it illustrates the gap between typical supplementation and actual needs during lactation.

For the mother postpartum, the same deficiency dynamics that applied during pregnancy continue. Sleep deprivation, indoor time with a newborn, and potential weight retention all contribute to lower 25(OH)D. The Rays guide on how long outside for vitamin D is a practical starting point for understanding what outdoor time can realistically contribute when season and latitude allow.

Skin Tone, Season, and Equity in Gestational Deficiency

Darker skin tones require roughly 3–5 times more sun exposure than lighter skin to generate equivalent vitamin D, because melanin competes with 7-dehydrocholesterol for UVB photons. This biological difference means that women with darker skin who live at higher latitudes face compounding disadvantages: reduced UVB availability in autumn and winter, and lower synthesis efficiency when UVB is available. Studies consistently show higher rates of gestational vitamin D deficiency among Black, South Asian, and Middle Eastern women living in Northern Europe and North America — groups who are also more likely to receive inadequate supplementation due to systemic gaps in prenatal care.

A 2013 cohort study in PLoS ONE found that over 75% of pregnant South Asian women in the UK had 25(OH)D below 25 nmol/L (10 ng/mL) at delivery — a profoundly deficient level — compared with 31% of white European women in the same sample. This is not a lifestyle gap; it is a physiological and structural one that supplementation can address.

Key Takeaways

Vitamin D demand rises steadily across all three trimesters as the placenta, fetal skeleton, and immune development all draw on maternal 25(OH)D. The standard prenatal vitamin at 400–600 IU/day is insufficient for most women to maintain levels above 30 ng/mL, and the trial evidence supports supplementation in the 1,500–4,000 IU/day range under clinical guidance. D3 is the preferred form, taken with food. Testing 25(OH)D at the first prenatal visit and again in the third trimester allows targeted adjustment. Women with darker skin tones and those living at higher latitudes — especially in winter — have the highest risk and the least ability to rely on sun alone. Breast milk alone does not supply adequate vitamin D to infants; either infant supplementation or high-dose maternal supplementation is necessary postpartum.

What to do next

If you're pregnant or planning to become pregnant, start by knowing your baseline 25(OH)D. Use the Rays vitamin D calculator to estimate whether your current sun exposure can contribute meaningfully given your location, skin type, and season — or whether supplementation needs to carry the load. For ongoing tracking through pregnancy and postpartum, Rays automatically detects outdoor time and sun conditions so you don't have to log sessions manually. Pair that with your 25(OH)D test results and your prenatal care team's guidance for the most evidence-grounded approach.